Institutional Ownership
Olema Pharmaceuticals Inc
CUSIP 68062P106COMOLMAQ1 2026
13D / 13G Filings
50
Schedule 13D/13G on record
Beneficial Filers
16
Distinct reporting persons
Largest Stake
14.3%
Max % of class reported
Institutional Holders
189
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
50 filings · latest Mar 6, 2026
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Mar 6, 2026 | Fmr LLC | 13G/A | 12.5% | 10.00M | SEC |
| 2 | Feb 17, 2026 | Janus Henderson Group PLC | 13G/A | 8.4% | 6.71M | SEC |
| 3 | Feb 17, 2026 | Bain Capital Life Sciences Opportunities IV, L.P. | 13G/A | 10.0% | 8.51M | SEC |
| 4 | Feb 13, 2026 | Deep Track Capital, LP | 13G/A | — | — | SEC |
| 5 | Feb 5, 2026 | Fmr LLC | 13G | 6.3% | 5.02M | SEC |
| 6 | Nov 14, 2025 | Janus Henderson Group PLC | 13G | 5.2% | 3.59M | SEC |
| 7 | May 15, 2025 | Deep Track Capital, LP | 13G/A | 5.0% | 3.44M | SEC |
| 8 | May 15, 2025 | Bain Capital Life Sciences Opportunities IV, L.P. | 13G/A | 10.0% | 6.84M | SEC |
| 9 | May 15, 2025 | Point72 Asset Management, L.P. | 13G/A | 2.3% | 1.54M | SEC |
| 10 | May 13, 2025 | Logos Global Management LP | 13D/A | 4.7% | — | SEC |
40 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Olema Pharmaceuticals Inc.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Fmr LLC | 10.39M | $154.87M |
| 2 | Paradigm Biocapital Advisors LP | 8.02M | $119.59M |
| 3 | Bain Capital Life Sciences Investors, LLC | 7.47M | $111.43M |
| 4 | Janus Henderson Group PLC | 7.11M | $106.01M |
| 5 | Blackrock, Inc. | 5.65M | $84.27M |
| 6 | Bvf Inc/Il | 5.30M | $78.96M |
| 7 | Siren, L.L.C. | 4.76M | $70.93M |
| 8 | State Street Corp | 3.94M | $58.71M |
| 9 | Cormorant Asset Management, LP | 3.90M | $58.15M |
| 10 | Logos Global Management LP | 3.21M | $47.84M |